We are proud to announce that ACARE has partnered with ITACA, the Italian Network for Hereditary and Acquired Angioedema. ACARE and ITACA share common interests, and members of both networks are expert centers for all forms of angioedema and can diagnose, certify and treat HAE as well as angioedema due to acquired C1INH-deficency, contact system activation and mast cell degranulation.
ACARE and ITACA centers employ a multidisciplinary approach and are able to address any clinical needs in pediatric and adult populations. From now on, ITACA will guide their member centers in becoming ACAREs and audits will be conducted jointly (with final approval by the ACARE Steering Committee).
We are looking forward to this undoubtedly fruitful collaboration and to gaining many new ACARE centers in Italy.
Read more news from ACARE
- March 28, 2023
STATE OF THE ART MANAGEMENT OF RECURRENT ANGIOEDEMA AND HANDS ON TRAINING with special focus on Canada and Europe (applied for CME) Click here to register. The overall aim [...]
- May 2, 2024
REGISTER NOW TOPIC: ACTUAL TREATMENT APPROACH IN HAE: A PERSPECTIVE FROM DIFFERENT CONTINENTS WITH A FOCUS ON GROWTH AND EMERGING MARKETS (GEMS) DATE: May 14th, 2024, 2:00 – 3:00 pm [...]
- October 26, 2023
Join Dr. Antonia Scherer and Dr. Thomas Buttgereit as they discuss the impact of recurrent hereditary angioedema on the larynx. Drawing from her perspective as an ENT expert, Dr Scherer [...]
